Results from the pivotal phase (Ph) 2b HERIZON-BTC-01 study: Zanidatamab in previously-treated HER2-amplified biliary tract cancer (BTC) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pant, Shubham
  • Fan, Jia
  • Oh, Do-Youn
  • Choi, Hye Jin
  • Kim, Jin Won
  • Chang, Heung-Moon
  • Bao, Lequn
  • Sun, Hui-Chuan
  • Mercade, Teresa Macarulla
  • Xie, Feng
  • Metges, Jean Philippe
  • Jieer, Ying
  • Bridgewater, John A
  • Tejani, Mohamedtaki Abdulaziz
  • Chen, Emerson Yu-Sheng
  • Wasan, Harpreet Singh
  • Ducreux, Michel Pierre
  • Ma, Jia-Fang
  • Garfin, Phillip M
  • Harding, James J

publication date

  • June 1, 2023